Quantcast
Last updated on April 24, 2014 at 17:35 EDT

Latest Oncology Stories

2014-04-01 08:29:06

VIENNA, Austria, April 1, 2014 /PRNewswire/ -- Kaiser-Franz-Josef Hospital in Vienna has become one of the first oncology departments in Europe to introduce clinical treatments using the PerfectPitch(TM) six-degrees-of-freedom robotic couch from Varian Medical Systems (NYSE: VAR). The hospital has introduced this enhanced patient positioning device, which enables more flexibility during radiotherapy treatments, as an integrated element of its latest TrueBeam(TM) 2.0 treatment system....

2014-03-31 23:32:02

Bladder cancer patients with metabolic syndrome – a set of conditions closely related to diabetes risk – are more likely to have a more invasive and fast-growing form of the disease. Raleigh, NC (PRWEB) March 31, 2014 A team of Turkish urology specialists have concluded that bladder cancer is more likely to be of a higher stage and grade in patients who also suffer from metabolic syndrome or diabetes. The results of their new analysis have just been posted on the on Cancer Monthly...

2014-03-31 23:30:05

The Mesothelioma Applied Research Foundation (Meso Foundation) awarded Congresswomen Betty McCollum and Chellie Pingree the Bruce Vento Hope-Builder Award, for sending a letter to Dr. Harold Varmus, Director of the National Cancer Institute, to urge the National Cancer Institute to further mesothelioma research. Alexandria, VA (PRWEB) March 31, 2014 Earlier this month, the Mesothelioma Applied Research Foundation (Meso Foundation) awarded Congresswomen Betty McCollum and Chellie Pingree...

2014-03-31 23:25:26

New research report “NSCLC Therapeutics in Asia-Pacific Markets to 2019 - Personalized Therapies Focus on Untapped Segment of Squamous Cell Carcinoma to Expand Treatment Pool” worked out by GBI Research is now available at MarketPublishers.com. According to the study, the APAC NSCLC market is predicted to post a 6.3% CAGR to amount to USD 2.9 billion by 2019. London, UK (PRWEB) March 31, 2014 As for 2012, the non-small cell lung cancer (NSCLC) market in the APAC region was evaluated...

2014-03-31 23:24:01

Mediaplanet’s campaign sheds light on advancements in treatment and technology of cancer care in the 21st century, providing a special focus on breast cancer awareness and advocacy. San Francisco, CA (PRWEB) March 31, 2014 “Innovations in Cancer Care”, a cross-platform awareness campaign produced by Mediaplanet, launches today as a 12-page print publication within the San Francisco Chronicle and as a site distributed across a network of online platforms. The campaign will reach over...

2014-03-31 23:01:36

During the first week of April, the Mesothelioma Applied Research Foundation (Meso Foundation) will observe Asbestos Awareness Week while raising awareness of the deep damage inflicted by asbestos’ use and the overdue need for life-saving treatments and a cure for those who have already developed, or who will develop, mesothelioma. Mesothelioma is a cancer known to be caused by exposure to asbestos. Alexandria, VA (PRWEB) March 31, 2014 During the first week of April, the Mesothelioma...

2014-03-31 12:10:17

Nearly half of patients with the most common form of adult leukemia are said to have normal chromosomes but appear instead to have a distinct pattern of genetic abnormalities that could better define their prognosis and treatment, researchers report. Using microarray technology that probes millions of genes within chromosomes, researchers found the unique pattern in the leukemia cells of 22 patients diagnosed with cytogenetically normal acute myelogenous leukemia, said Dr. Ravindra Kolhe,...

2014-03-31 09:54:57

UT Southwestern Medical Center researchers are developing a new predictive tool that could help patients with breast cancer and certain lung cancers decide whether follow-up treatments are likely to help. Dr. Jerry Shay, Vice Chairman and Professor of Cell Biology at UT Southwestern, led a three-year study on the effects of irradiation in a lung cancer-susceptible mouse model. When his team looked at gene expression changes in the mice, then applied them to humans with early stage cancer,...

2014-03-31 08:30:12

Agreement Will Accelerate Clinical Trial Research and Improve Patient Outcomes BLUE BELL, Pa., March 31, 2014 /PRNewswire/ -- United BioSource Corp. (UBC), a subsidiary of Express Scripts (NASDAQ: ESRX), has been named the preferred oncology clinical research partner by RT Oncology Services Corp. (RainTree), the nation's leading community oncology alliance. The agreement seeks to improve patient care by accelerating clinical research in the U.S. UBC is a market leader in the design...

2014-03-31 08:29:56

BERGISCH GLADBACH, Germany, March 31, 2014 /PRNewswire/ -- Varian Medical Systems (NYSE: VAR) and the Paul Scherrer Institute (PSI) are announcing an extension of their existing collaboration in the field of proton therapy to offer patients more precise cancer treatments using intensity modulated proton therapy (IMPT). Under the agreement, Varian will also supply technology and equipment to help meet a growing demand for clinical research and treatments at PSI. Proton therapy...